The end of an era is nearing for Lundbeck. After a 17-year collaboration with Takeda on depression drug Trintellix, the Danish drugmaker is passing over its U.S. rights to its partner. Effective ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback